Development of peptide conjugated superparamagnetic iron oxide (SPIO) nanoparticles for targeted MR imaging and therapy of pancreatic cancer

Lily Yang, Hui Mao, Zehong Cao, Andrew Wang, Xianghong Peng, Xiaoxia Wang, Prasanthi Karna, Gregory Adams, Qingan Yuan, Charles Staley, William C. Wood, Shuming Nie, Xiaohu Gao

Research output: Chapter in Book/Report/Conference proceedingConference contribution

Abstract

Development of multifunctional nanoparticles that selectively target to human tumors for in vivo tumor imaging as well as inhibition of tumor growth holds a great promise for improving survival rate of cancer patients. In this study, we have engineered peptide conjugated superparamagnetic iron oxide (SPIO) nanoparticles targeting to urokinase plasminogen activator receptor (uPAR) or a single chain antibody to epidermal growth factor receptor (ScFvEGFR), which are highly expressed in human pancreatic cancer tissues. We demonstrated that the SPIO nanoparticles bind to and are internalized by pancreatic cancer cells in vitro, resulting a significant shortened T2 detected by MRI scan and positive Prussian blue staining in the tumor cells. Furthermore, the targeted-SPIO nanoparticles markedly inhibited the growth of pancreatic cancer cells in vitro. Using an orthotopic human pancreatic cancer xenograft model in nude mice, in vivo MRI demonstrated that systemic delivery of the targeted SPIO nanoparticles leads to accumulation of the 10 nanoparticles in intra-pancreatic tumors causing a significant signal drop in those areas. Examination of tissue distribution of the target-IO nanoparticles by Prussian blue staining of frozen tissue sections showed high levels of iron staining in pancreatic cancer lesions but not in adjacent normal pancreas. Normal liver and spleen also displayed high levels of iron staining, while normal lung tissue had a low level of iron staining. Both kidney and heart tissues lacked iron staining. Therefore, those multifunctional nanoparticles have potential for the development of tumor-targeted imaging probes and drug delivery particles for the detection and treatment of pancreatic cancer.

Original languageEnglish (US)
Title of host publication2006 NSTI Nanotechnology Conference and Trade Show - NSTI Nanotech 2006 Technical Proceedings
Pages17-20
Number of pages4
StatePublished - Dec 8 2006
Event2006 NSTI Nanotechnology Conference and Trade Show - NSTI Nanotech 2006 Technical Proceedings - Boston, MA, United States
Duration: May 7 2006May 11 2006

Publication series

Name2006 NSTI Nanotechnology Conference and Trade Show - NSTI Nanotech 2006 Technical Proceedings
Volume2

Other

Other2006 NSTI Nanotechnology Conference and Trade Show - NSTI Nanotech 2006 Technical Proceedings
CountryUnited States
CityBoston, MA
Period5/7/065/11/06

Fingerprint

Iron oxides
Peptides
Nanoparticles
Imaging techniques
Tumors
Tissue
Iron
Cells
Drug delivery
Antibodies
Liver
Magnetic resonance imaging

Keywords

  • EGFR
  • MRI
  • Pancreatic cancer
  • Tumor targeted nanoparticles
  • uPAR

ASJC Scopus subject areas

  • Engineering(all)

Cite this

Yang, L., Mao, H., Cao, Z., Wang, A., Peng, X., Wang, X., ... Gao, X. (2006). Development of peptide conjugated superparamagnetic iron oxide (SPIO) nanoparticles for targeted MR imaging and therapy of pancreatic cancer. In 2006 NSTI Nanotechnology Conference and Trade Show - NSTI Nanotech 2006 Technical Proceedings (pp. 17-20). (2006 NSTI Nanotechnology Conference and Trade Show - NSTI Nanotech 2006 Technical Proceedings; Vol. 2).

Development of peptide conjugated superparamagnetic iron oxide (SPIO) nanoparticles for targeted MR imaging and therapy of pancreatic cancer. / Yang, Lily; Mao, Hui; Cao, Zehong; Wang, Andrew; Peng, Xianghong; Wang, Xiaoxia; Karna, Prasanthi; Adams, Gregory; Yuan, Qingan; Staley, Charles; Wood, William C.; Nie, Shuming; Gao, Xiaohu.

2006 NSTI Nanotechnology Conference and Trade Show - NSTI Nanotech 2006 Technical Proceedings. 2006. p. 17-20 (2006 NSTI Nanotechnology Conference and Trade Show - NSTI Nanotech 2006 Technical Proceedings; Vol. 2).

Research output: Chapter in Book/Report/Conference proceedingConference contribution

Yang, L, Mao, H, Cao, Z, Wang, A, Peng, X, Wang, X, Karna, P, Adams, G, Yuan, Q, Staley, C, Wood, WC, Nie, S & Gao, X 2006, Development of peptide conjugated superparamagnetic iron oxide (SPIO) nanoparticles for targeted MR imaging and therapy of pancreatic cancer. in 2006 NSTI Nanotechnology Conference and Trade Show - NSTI Nanotech 2006 Technical Proceedings. 2006 NSTI Nanotechnology Conference and Trade Show - NSTI Nanotech 2006 Technical Proceedings, vol. 2, pp. 17-20, 2006 NSTI Nanotechnology Conference and Trade Show - NSTI Nanotech 2006 Technical Proceedings, Boston, MA, United States, 5/7/06.
Yang L, Mao H, Cao Z, Wang A, Peng X, Wang X et al. Development of peptide conjugated superparamagnetic iron oxide (SPIO) nanoparticles for targeted MR imaging and therapy of pancreatic cancer. In 2006 NSTI Nanotechnology Conference and Trade Show - NSTI Nanotech 2006 Technical Proceedings. 2006. p. 17-20. (2006 NSTI Nanotechnology Conference and Trade Show - NSTI Nanotech 2006 Technical Proceedings).
Yang, Lily ; Mao, Hui ; Cao, Zehong ; Wang, Andrew ; Peng, Xianghong ; Wang, Xiaoxia ; Karna, Prasanthi ; Adams, Gregory ; Yuan, Qingan ; Staley, Charles ; Wood, William C. ; Nie, Shuming ; Gao, Xiaohu. / Development of peptide conjugated superparamagnetic iron oxide (SPIO) nanoparticles for targeted MR imaging and therapy of pancreatic cancer. 2006 NSTI Nanotechnology Conference and Trade Show - NSTI Nanotech 2006 Technical Proceedings. 2006. pp. 17-20 (2006 NSTI Nanotechnology Conference and Trade Show - NSTI Nanotech 2006 Technical Proceedings).
@inproceedings{b3e18bad9cde40c4b00326e5bb1dc752,
title = "Development of peptide conjugated superparamagnetic iron oxide (SPIO) nanoparticles for targeted MR imaging and therapy of pancreatic cancer",
abstract = "Development of multifunctional nanoparticles that selectively target to human tumors for in vivo tumor imaging as well as inhibition of tumor growth holds a great promise for improving survival rate of cancer patients. In this study, we have engineered peptide conjugated superparamagnetic iron oxide (SPIO) nanoparticles targeting to urokinase plasminogen activator receptor (uPAR) or a single chain antibody to epidermal growth factor receptor (ScFvEGFR), which are highly expressed in human pancreatic cancer tissues. We demonstrated that the SPIO nanoparticles bind to and are internalized by pancreatic cancer cells in vitro, resulting a significant shortened T2 detected by MRI scan and positive Prussian blue staining in the tumor cells. Furthermore, the targeted-SPIO nanoparticles markedly inhibited the growth of pancreatic cancer cells in vitro. Using an orthotopic human pancreatic cancer xenograft model in nude mice, in vivo MRI demonstrated that systemic delivery of the targeted SPIO nanoparticles leads to accumulation of the 10 nanoparticles in intra-pancreatic tumors causing a significant signal drop in those areas. Examination of tissue distribution of the target-IO nanoparticles by Prussian blue staining of frozen tissue sections showed high levels of iron staining in pancreatic cancer lesions but not in adjacent normal pancreas. Normal liver and spleen also displayed high levels of iron staining, while normal lung tissue had a low level of iron staining. Both kidney and heart tissues lacked iron staining. Therefore, those multifunctional nanoparticles have potential for the development of tumor-targeted imaging probes and drug delivery particles for the detection and treatment of pancreatic cancer.",
keywords = "EGFR, MRI, Pancreatic cancer, Tumor targeted nanoparticles, uPAR",
author = "Lily Yang and Hui Mao and Zehong Cao and Andrew Wang and Xianghong Peng and Xiaoxia Wang and Prasanthi Karna and Gregory Adams and Qingan Yuan and Charles Staley and Wood, {William C.} and Shuming Nie and Xiaohu Gao",
year = "2006",
month = "12",
day = "8",
language = "English (US)",
isbn = "0976798573",
series = "2006 NSTI Nanotechnology Conference and Trade Show - NSTI Nanotech 2006 Technical Proceedings",
pages = "17--20",
booktitle = "2006 NSTI Nanotechnology Conference and Trade Show - NSTI Nanotech 2006 Technical Proceedings",

}

TY - GEN

T1 - Development of peptide conjugated superparamagnetic iron oxide (SPIO) nanoparticles for targeted MR imaging and therapy of pancreatic cancer

AU - Yang, Lily

AU - Mao, Hui

AU - Cao, Zehong

AU - Wang, Andrew

AU - Peng, Xianghong

AU - Wang, Xiaoxia

AU - Karna, Prasanthi

AU - Adams, Gregory

AU - Yuan, Qingan

AU - Staley, Charles

AU - Wood, William C.

AU - Nie, Shuming

AU - Gao, Xiaohu

PY - 2006/12/8

Y1 - 2006/12/8

N2 - Development of multifunctional nanoparticles that selectively target to human tumors for in vivo tumor imaging as well as inhibition of tumor growth holds a great promise for improving survival rate of cancer patients. In this study, we have engineered peptide conjugated superparamagnetic iron oxide (SPIO) nanoparticles targeting to urokinase plasminogen activator receptor (uPAR) or a single chain antibody to epidermal growth factor receptor (ScFvEGFR), which are highly expressed in human pancreatic cancer tissues. We demonstrated that the SPIO nanoparticles bind to and are internalized by pancreatic cancer cells in vitro, resulting a significant shortened T2 detected by MRI scan and positive Prussian blue staining in the tumor cells. Furthermore, the targeted-SPIO nanoparticles markedly inhibited the growth of pancreatic cancer cells in vitro. Using an orthotopic human pancreatic cancer xenograft model in nude mice, in vivo MRI demonstrated that systemic delivery of the targeted SPIO nanoparticles leads to accumulation of the 10 nanoparticles in intra-pancreatic tumors causing a significant signal drop in those areas. Examination of tissue distribution of the target-IO nanoparticles by Prussian blue staining of frozen tissue sections showed high levels of iron staining in pancreatic cancer lesions but not in adjacent normal pancreas. Normal liver and spleen also displayed high levels of iron staining, while normal lung tissue had a low level of iron staining. Both kidney and heart tissues lacked iron staining. Therefore, those multifunctional nanoparticles have potential for the development of tumor-targeted imaging probes and drug delivery particles for the detection and treatment of pancreatic cancer.

AB - Development of multifunctional nanoparticles that selectively target to human tumors for in vivo tumor imaging as well as inhibition of tumor growth holds a great promise for improving survival rate of cancer patients. In this study, we have engineered peptide conjugated superparamagnetic iron oxide (SPIO) nanoparticles targeting to urokinase plasminogen activator receptor (uPAR) or a single chain antibody to epidermal growth factor receptor (ScFvEGFR), which are highly expressed in human pancreatic cancer tissues. We demonstrated that the SPIO nanoparticles bind to and are internalized by pancreatic cancer cells in vitro, resulting a significant shortened T2 detected by MRI scan and positive Prussian blue staining in the tumor cells. Furthermore, the targeted-SPIO nanoparticles markedly inhibited the growth of pancreatic cancer cells in vitro. Using an orthotopic human pancreatic cancer xenograft model in nude mice, in vivo MRI demonstrated that systemic delivery of the targeted SPIO nanoparticles leads to accumulation of the 10 nanoparticles in intra-pancreatic tumors causing a significant signal drop in those areas. Examination of tissue distribution of the target-IO nanoparticles by Prussian blue staining of frozen tissue sections showed high levels of iron staining in pancreatic cancer lesions but not in adjacent normal pancreas. Normal liver and spleen also displayed high levels of iron staining, while normal lung tissue had a low level of iron staining. Both kidney and heart tissues lacked iron staining. Therefore, those multifunctional nanoparticles have potential for the development of tumor-targeted imaging probes and drug delivery particles for the detection and treatment of pancreatic cancer.

KW - EGFR

KW - MRI

KW - Pancreatic cancer

KW - Tumor targeted nanoparticles

KW - uPAR

UR - http://www.scopus.com/inward/record.url?scp=33845232283&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33845232283&partnerID=8YFLogxK

M3 - Conference contribution

AN - SCOPUS:33845232283

SN - 0976798573

SN - 9780976798576

T3 - 2006 NSTI Nanotechnology Conference and Trade Show - NSTI Nanotech 2006 Technical Proceedings

SP - 17

EP - 20

BT - 2006 NSTI Nanotechnology Conference and Trade Show - NSTI Nanotech 2006 Technical Proceedings

ER -